As one of the fastest-rising categories of healthcare costs, pharmaceuticals need to develop a metric that explains pricing.
Having an impact on outcomes requires understanding the everyday challenges and barriers to healthcare.
Think Darwinism doesn't apply to your business? Think again.
US-funded global health R&D is advancing innovations that are improving health worldwide, and it is also paying huge dividends for America.
Artificial intelligence is helping the industry utilize algorithms to make better sense of mountains upon mountains of data to offer patients more personalized care. Here's how investors and innovators can take advantage of the AI revolution?
Analysis details how the reinstated health insurance tax will impact premiums. Key finding: Next year, enrollees across markets can expect to pay 2.7% more.
Five steps healthcare leaders can take to help tackle consumers’ most pressing jobs to be done and become truly consumer-centric.
Oliver Wyman’s sister firm, Lippincott, predicts six fundamental shifts that will create the customer of the future and how companies need to prepare.
While the Graham-Cassidy bill failed to come to a vote keeping ACA as the law of the land, changes are coming. Here are four ways to react.
What lies ahead for insurers as the ACA 2018 open enrollment period approaches.
Metabolic syndrome affects 1 in 3 people—making it as common as the common cold. Learn why Newtopia is prioritizing this condition to improve employee well-being.
Why healthcare organizations must start thinking about product development and management the way creative software companies do. And how to begin.
How Castlight is pushing the evolution of health benefit solutions.